Insight

Stephen V Liu: Beautiful Review on Neoadjuvant Immunotherapy Across Tumor Types

Stephen V Liu/X

Jun 25, 2025, 23:31

Stephen V Liu: Beautiful Review on Neoadjuvant Immunotherapy Across Tumor Types

Stephen V Liu, Director of Thoracic Oncology and Associate Professor of Medicine at Georgetown University, shared a post on X:

“Beautiful review on neoadjuvant immunotherapy across tumor types and how we can further refine delivery and develop biomarkers, Nature Cancer.

Congratulations to Drs. Gil Awada, Tina Cascone, Michiel van der Heijden, Christian Blank, Marleen Kok, Myriam Chalabi.”

Title: The rapidly evolving paradigm of neoadjuvant immunotherapy across cancer types

Journal: Nature Cancer

Authors: Gil Awada, Tina Cascone, Michiel S. van der Heijden, Christian U. Blank, Marleen Kok, Myriam Chalabi

Read the full article.

Stephen V Liu: Beautiful Review on Neoadjuvant Immunotherapy Across Tumor Types

More posts featuring Stephen V Liu on OncoDaily.

cancer Christian Blank Christian U. Blank Georgetown University Gil Awada Marleen Kok Michiel S. Van der Heijden Michiel van der Heijden Myriam Chalabi OncoDaily Oncology Stephen V Liu Tina Cascone

Tabelecleucel (Ebvallo) FDA Update: Approval Delayed Despite Positive Phase 3 Data

New Paper Alert: Breakthrough iNKT Cell Therapy Achieves Complete Remission in Metastatic Germ Cell Tumor

"God Invented This" - Pat Soon-Shiong on Cancer Discovery

Yüksel Ürün: Science Is Better When It’s Shared

Oliver Bogler: Grant Tips